◼ Archived
Health
🔮 fades ✓
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
GLP-1s
6 independently sourced, verified news trends involving GLP-1s.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jun 29, 2026 through Aug 6, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Health
🔮 holds ✗
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
Use of GLP-1 weight loss medications has reached a new high in the United States, sparking debate over long-term efficacy and accessibility.
◼ Archived
Health
🔮 fades ✗
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
A new economic study suggests a correlation between the use of GLP-1 weight-loss drugs and a 17% reduction in employee sick leave.
◼ Archived
Health
🔮 holds ✗
Does stopping a GLP-1 really doom you to regain all the weight?
Recent studies examine the long-term impact of discontinuing GLP-1 weight-loss medications like Ozempic and Wegovy.
◼ Archived
Business
🔮 holds ✗
Why your health plan doesn’t cover GLP-1s, according to a top insurance exec
Rising demand for GLP-1 weight-loss medications is straining budgets and prompting insurers and employers to limit coverage.
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Medical researchers and clinicians are investigating whether GLP-1 weight loss drugs like Ozempic offer benefits beyond weight reduction, including longevity.